Vandenbulcke Bo, Verhaeghe Nick, Cruycke Lisa, Lelie Max, Simoens Steven, Putman Koen
Department of Public Health, Interuniversity Centre for Health Economics Research (i-CHER), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium.
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, ON2 Herestraat 49, P.O. Box 521, 3000 Leuven, Belgium.
Int J Environ Res Public Health. 2025 Jun 11;22(6):926. doi: 10.3390/ijerph22060926.
Air pollution is the world's greatest environmental health risk. Pollutants that pose large health concerns are particulate matter (PM and PM), ozone (O), carbon monoxide (CO), nitrogen dioxide (NO), and sulphur dioxide (SO). These compounds (especially PM and PM) contribute to the onset of diseases, such as respiratory diseases (e.g., asthma, chronic obstructive pulmonary disease (COPD), or lung cancer) and cardiovascular diseases. Abatement interventions are implemented to reduce air pollution and thereby the risk of these diseases. This systematic review examined the published scientific evidence on the cost-effectiveness of strategies aimed at reducing or controlling air pollution and assessed the reporting quality of included studies. It employed rigorous data extraction and quality scoring procedures to ensure the reliability and validity of our findings. Overall, there is substantial evidence supporting the cost-effectiveness of interventions aimed at reducing air pollution. Seventy-four studies and four policy reports were included in this review. Predominantly, cost-benefit analyses have been reported ( = 40), reflecting the multisectoral impacts and associated costs of air pollution. Only four cost-utility analyses were found, indicating the need for more research within this domain. Additionally, eight articles reported one or more non-economic results. Thirty-nine studies focused on particulate matter (PM), and eleven focused on nitrogen oxides (NOx). The quality assessment yielded moderate results. The heterogeneity of studies and moderate quality of reporting make it difficult to compare results and draw definitive conclusions.
空气污染是全球最大的环境健康风险。引发重大健康问题的污染物包括颗粒物(PM和PM)、臭氧(O)、一氧化碳(CO)、二氧化氮(NO)和二氧化硫(SO)。这些化合物(尤其是PM和PM)会导致疾病的发生,如呼吸系统疾病(如哮喘、慢性阻塞性肺疾病(COPD)或肺癌)和心血管疾病。为减少空气污染从而降低这些疾病的风险,人们实施了减排干预措施。本系统综述考察了已发表的关于旨在减少或控制空气污染的策略的成本效益的科学证据,并评估了纳入研究的报告质量。它采用了严格的数据提取和质量评分程序,以确保我们研究结果的可靠性和有效性。总体而言,有大量证据支持旨在减少空气污染的干预措施的成本效益。本综述纳入了74项研究和4份政策报告。主要报告的是成本效益分析( = 40),反映了空气污染的多部门影响和相关成本。仅发现4项成本效用分析,表明该领域需要更多研究。此外,8篇文章报告了一项或多项非经济结果。39项研究关注颗粒物(PM),11项关注氮氧化物(NOx)。质量评估得出中等结果。研究的异质性和报告质量中等使得难以比较结果并得出明确结论。